Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Etsuko YAMAMOTO HATTORI"'
Autor:
Masayoshi Kawata, Atsushi Yonezawa, Yohei Mineharu, Kotaro Itohara, Toshiyuki Mizota, Yoshihiro Matsui, Takayuki Kikuchi, Yukihiro Yamao, Etsuko Yamamoto Hattori, Miho Hamada, Daiki Hira, Keiko Furukawa, Susumu Miyamoto, Tomohiro Terada, Kazuo Matsubara, Yoshiki Arakawa
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract Propofol’s pharmacokinetics have been extensively studied using human blood samples and applied to target-controlled infusion systems; however, information on its concentration in the brain remains scarce. Therefore, this study aimed to si
Externí odkaz:
https://doaj.org/article/1d6cac383f944d16b7a93c10b969103c
Autor:
Etsuko Yamamoto Hattori, Yoshiki Arakawa, Yohei Mineharu, Keiko Furukawa, Yukinori Terada, Yukihiro Yamao, Masahiro Tanji, Takayuki Kikuchi, Susumu Miyamoto
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background Epilepsy is a major symptom in patients with glioma. Levetiracetam (LEV) is recognized as a first-line treatment for glioma-related epilepsy. Increasing the LEV dose is allowed into patients with seizure occurrence against its ini
Externí odkaz:
https://doaj.org/article/64cbd2b46ffc49aeb50d228a82faa4ae
Autor:
Etsuko Yamamoto Hattori, Tatsuya Masuda, Yohei Mineharu, Masamitsu Mikami, Yukinori Terada, Yasuzumi Matsui, Hirohito Kubota, Hidemasa Matsuo, Masahiro Hirata, Tatsuki R. Kataoka, Tatsutoshi Nakahata, Shuji Ikeda, Susumu Miyamoto, Hiroshi Sugiyama, Yoshiki Arakawa, Yasuhiko Kamikubo
Publikováno v:
Communications Biology, Vol 5, Iss 1, Pp 1-11 (2022)
Interfering with RUNX family proteins reduces glioblastoma growth in mice and reveals pathways involved in the maintenance of tumour growth.
Externí odkaz:
https://doaj.org/article/20df2f30c17f41118ba3ebebeae13918
Autor:
Masayoshi KAWATA, Ayaka FUKUI, Yohei MINEHARU, Takayuki KIKUCHI, Yukihiro YAMAO, Etsuko YAMAMOTO HATTORI, Atsuko SHIRAKI, Toshiyuki MIZOTA, Keiko FURUKAWA, Susumu MIYAMOTO, Atsushi YONEZAWA, Yoshiki ARAKAWA
Publikováno v:
Neurologia Medico-Chirurgica, Vol 62, Iss 6, Pp 278-285 (2022)
The number of awake craniotomies is increasing because of its beneficial features. However, not enough information is available regarding the current status of awake craniotomy in Japan. To evaluate the current status of awake craniotomy in institute
Externí odkaz:
https://doaj.org/article/d83bd19bea814467951187470de82f4d
Autor:
Etsuko Yamamoto Hattori, Tatsuya Masuda, Yohei Mineharu, Masamitsu Mikami, Yukinori Terada, Yasuzumi Matsui, Hirohito Kubota, Hidemasa Matsuo, Masahiro Hirata, Tatsuki R. Kataoka, Tatsutoshi Nakahata, Shuji Ikeda, Susumu Miyamoto, Hiroshi Sugiyama, Yoshiki Arakawa, Yasuhiko Kamikubo
Publikováno v:
Communications Biology, Vol 5, Iss 1, Pp 1-1 (2022)
Externí odkaz:
https://doaj.org/article/fb1ad7a72f9f423484d4b5a0ffcf5c65
Autor:
Shunya Kashiwagi, Masahiro Tanji, Toshiki Matsuoka, Noritaka Sano, Hiroaki Ozasa, Daisuke Natori, Yasuhide Takeuchi, Yasuhide Makino, Etsuko Yamamoto Hattori, Yukinori Terada, Yohei Mineharu, Yoshiki Arakawa
Publikováno v:
Journal of Neurosurgery Case Lessons; Aug2024, Vol. 8 Issue 7, p1-5, 5p
Autor:
Shintaro Nakayasu, Masahiro Tanji, Megumi Uto, Yasuhide Takeuchi, Yasuhide Makino, Etsuko Yamamoto Hattori, Yukinori Terada, Noritaka Sano, Yohei Mineharu, Takashi Mizowaki
Publikováno v:
Journal of Neurosurgery Case Lessons; Aug2024, Vol. 8 Issue 7, p1-6, 6p
Autor:
Masamitsu Mikami, Tatsuya Masuda, Takuya Kanatani, Mina Noura, Katsutsugu Umeda, Hidefumi Hiramatsu, Hirohito Kubota, Tomoo Daifu, Atsushi Iwai, Etsuko Yamamoto Hattori, Kana Furuichi, Saho Takasaki, Sunao Tanaka, Yasuzumi Matsui, Hidemasa Matsuo, Masahiro Hirata, Tatsuki R. Kataoka, Tatsutoshi Nakahata, Yasumichi Kuwahara, Tomoko Iehara, Hajime Hosoi, Yoichi Imai, Junko Takita, Hiroshi Sugiyama, Souichi Adachi, Yasuhiko Kamikubo
Publikováno v:
Molecules and Cells. 45:886-895
Malignant rhabdoid tumor (MRT) is a highly aggressive pediatric malignancy with no effective therapy. Therefore, it is necessary to identify a target for the development of novel molecule-targeting therapeutic agents. In this study, we report the imp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::280cf66536984fe7c34cd6173969bef7
https://doi.org/10.14348/molcells.2022.2031
https://doi.org/10.14348/molcells.2022.2031
Autor:
Yasuzumi Matsui, Yohei Mineharu, Yuki Noguchi, Etsuko Yamamoto Hattori, Hirohito Kubota, Masahiro Hirata, Susumu Miyamoto, Hiroshi Sugiyama, Yoshiki Arakawa, Yasuhiko Kamikubo
Publikováno v:
Biochemical and Biophysical Research Communications. 620:150-157
Malignancy of medulloblastoma depends on its molecular classification. Sonic Hedgehog (SHH)-type medulloblastoma with p53 mutation was recognized as one of the most aggressive types of tumors. We developed a novel drug, chlorambucil-conjugated PI-pol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d14005996700681f6298df8c8726cad
https://doi.org/10.1016/j.bbrc.2022.06.090
https://doi.org/10.1016/j.bbrc.2022.06.090
Autor:
Takeyoshi Tsutsui, Taichi Ikedo, Yoshiaki Kitazawa, Ryotaro Otsuka, Takayuki Nishiwaki, Yuji Kushi, Akihiro Niwa, Saya Ozaki, Etsuko Yamamoto Hattori, Koji Shimonaga, Eika Hamano, Kiyofumi Yamada, Hirotoshi Imamura, Hisae Mori, Koji Iihara, Hiroharu Kataoka
Publikováno v:
World Neurosurgery.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5542ec44a3fd22d54769e1472cdb3903
https://doi.org/10.1016/j.wneu.2023.04.039
https://doi.org/10.1016/j.wneu.2023.04.039